The Antisera market size value per capita in Estonia has shown an overall upward trend from 2013 to 2023, with a notable dip in 2020. The value rose from $47.49 in 2013 to $74.6 in 2023. Between 2021 and 2022, the year-on-year variation was a slight decline of about 2.3%, following a surge of 29.8% in the previous year from 2020. The five-year Compound Annual Growth Rate (CAGR) suggests around 4.1% growth annually from 2018 to 2023.
Future trends to watch for include potential growth driven by increasing demand for healthcare products and technological advancements in pharmaceuticals. However, economic fluctuations and changes in healthcare policies could affect this trend.
